2,617 results on '"Dellon, Evan S."'
Search Results
2. Epidemiology and Racial Differences of EoE Patients in a U.S. Veterans Population
3. Vitamin D Levels as a Potential Modifier of Eosinophilic Esophagitis Severity in Adults
4. Harnessing Digital Pathology And Causal Learning To Improve Eosinophilic Esophagitis Dietary Treatment Assignment
5. Quantification of Mucosal Mast Cells in the Gastrointestinal Tract: A Primer for Practicing Pathologists
6. Eosinophilic Esophagitis: What’s in a Name?
7. Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years
8. Prevalence and Costs of Esophageal Strictures in the United States
9. Clinical and molecular correlates of the Index of Severity for Eosinophilic Esophagitis
10. Do General Pathologists Assess Gastric and Duodenal Eosinophilia? A Community-Based Study
11. Mast Cell Esophagitis: A Novel Entity in Patients with Unexplained Esophageal Symptoms
12. A Multicenter Long-Term Cohort Study of Eosinophilic Esophagitis Variants and Their Progression to Eosinophilic Esophagitis Over Time
13. DDS Profile: Evan S. Dellon, MD, MPH
14. Psychometric evaluation of the Dysphagia Symptom Questionnaire for adults and adolescents with eosinophilic esophagitis
15. A MULTICENTER LONG-TERM COHORT STUDY OF EOSINOPHILIC ESOPHAGITIS VARIANTS AND THEIR PROGRESSION TO EOE OVER TIME
16. Peripheral Blood IL5RA Gene Expression as a Diagnostic Biomarker for Eosinophilic Esophagitis
17. Pharmacologic Management of Non–Eosinophilic Esophagitis Eosinophilic Gastrointestinal Diseases
18. Artificial Intelligence Chatbot Shows Multiple Inaccuracies When Responding to Questions About Eosinophilic Esophagitis
19. Association between time from esophageal food impaction to endoscopy and adverse events
20. Persistent esophageal changes after histologic remission in eosinophilic esophagitis
21. The Index of Severity for Eosinophilic Esophagitis (I-SEE) Reflects Longitudinal Clinicopathologic Changes in Children
22. Qualitative assessment of the suitability of the Dysphagia Symptom Questionnaire to monitor dysphagia in children aged 7–10 years with eosinophilic esophagitis
23. The Impact of Obesity on the Fibrostenosis Progression of Eosinophilic Esophagitis in a U.S. Veterans Cohort
24. Real-World Efficacy of Dupilumab in Severe, Treatment-Refractory, and Fibrostenotic Patients With Eosinophilic Esophagitis
25. Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
26. Nonepithelial Gene Expression Correlates With Symptom Severity in Adults With Eosinophilic Esophagitis
27. Esophageal Candidiasis Is Strongly Associated With Treatment Response to Topical Steroids in Eosinophilic Esophagitis and Could Be a Marker of Adherence
28. CSTB and FABP5 Serum mRNA Differentiate Histologically Active and Inactive Patients With Eosinophilic Esophagitis
29. Determination of Optimal Eosinophil Thresholds for Diagnosis of Eosinophilic Gastritis and Duodenitis: A Pooled Analysis of 4 Prospective Studies
30. Worsened Fibrostenotic Outcomes in Eosinophilic Esophagitis Patients Due to COVID-19-Related Endoscopy Cancellations
31. Breakthroughs in understanding and treating eosinophilic gastrointestinal diseases presented at the CEGIR/TIGERs Symposium at the 2022 American Academy of Allergy, Asthma & Immunology Meeting
32. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
33. Epidemiologic Burden and Projections for Eosinophilic Esophagitis–Associated Emergency Department Visits in the United States: 2009-2030
34. Development and Validation of the Veterans Affairs Eosinophilic Esophagitis Cohort
35. Esophageal Epithelium and Lamina Propria Are Unevenly Involved in Eosinophilic Esophagitis
36. A Newly Proposed Severity Index for Eosinophilic Esophagitis is Associated With Baseline Clinical Features and Successful Treatment Response
37. Monitoring Patients With Eosinophilic Esophagitis in Routine Clinical Practice - International Expert Recommendations
38. Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases
39. Higher Body Mass Index Is Associated With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis
40. Eosinophilic esophagitis patients with multiple atopic conditions: Clinical characteristics and treatment response to topical steroids
41. Development of a Practical Guide to Implement and Monitor Diet Therapy for Eosinophilic Esophagitis
42. Nature with Nurture: the Role of Intrinsic Genetic and Extrinsic Environmental Factors on Eosinophilic Esophagitis
43. One-food versus six-food elimination diet therapy for the treatment of eosinophilic oesophagitis: a multicentre, randomised, open-label trial
44. High Discovery Rate of Duodenal and Gastric Eosinophilia in Patients With Unexplained Moderate–Severe Abdominal Symptoms: A Prospective US Multisite Study
45. Technical review on the management of eosinophilic esophagitis: a report from the AGA institute and the joint task force on allergy-immunology practice parameters
46. The potential for malignancy from atopic disorders and allergic inflammation: A systematic review and meta‐analysis
47. Molecular, endoscopic, histologic, and circulating biomarker-based diagnosis of eosinophilic gastritis: Multi-site study
48. Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick
49. Use of the Esophageal Sponge in Directing Food Reintroduction in Eosinophilic Esophagitis
50. Performance of an Artificial Intelligence Model for Recognition and Quantitation of Histologic Features of Eosinophilic Esophagitis on Biopsy Samples
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.